Stock Analysis on Net

HCA Healthcare Inc. (NYSE:HCA)

This company has been moved to the archive! The financial data has not been updated since May 3, 2022.

Enterprise Value to EBITDA (EV/EBITDA) 

Microsoft Excel

Earnings before Interest, Tax, Depreciation and Amortization (EBITDA)

HCA Healthcare Inc., EBITDA calculation

US$ in millions

Microsoft Excel
12 months ended: Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2017
Net income attributable to HCA Healthcare, Inc. 6,956 3,754 3,505 3,787 2,216
Add: Net income attributable to noncontrolling interest 765 633 640 602 527
Add: Income tax expense 2,112 1,043 1,099 946 1,638
Earnings before tax (EBT) 9,833 5,430 5,244 5,335 4,381
Add: Interest expense 1,566 1,584 1,824 1,755 1,690
Earnings before interest and tax (EBIT) 11,399 7,014 7,068 7,090 6,071
Add: Depreciation and amortization 2,853 2,721 2,596 2,278 2,131
Earnings before interest, tax, depreciation and amortization (EBITDA) 14,252 9,735 9,664 9,368 8,202

Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31).

Item Description The company
EBITDA To calculate EBITDA analysts start with net earnings. To that earnings number, interest, taxes, depreciation, and amortization are added. EBITDA as a pre-interest number is a flow to all providers of capital. HCA Healthcare Inc. EBITDA increased from 2019 to 2020 and from 2020 to 2021.

Enterprise Value to EBITDA Ratio, Current

HCA Healthcare Inc., current EV/EBITDA calculation, comparison to benchmarks

Microsoft Excel
Selected Financial Data (US$ in millions)
Enterprise value (EV) 99,463
Earnings before interest, tax, depreciation and amortization (EBITDA) 14,252
Valuation Ratio
EV/EBITDA 6.98
Benchmarks
EV/EBITDA, Competitors1
Abbott Laboratories 19.94
Cigna Group 11.05
CVS Health Corp. 7.03
Elevance Health Inc. 8.42
Humana Inc. 5.39
Intuitive Surgical Inc. 74.98
Medtronic PLC 16.19
UnitedHealth Group Inc. 16.07
EV/EBITDA, Sector
Health Care Equipment & Services 15.75
EV/EBITDA, Industry
Health Care 15.34

Based on: 10-K (reporting date: 2021-12-31).

1 Click competitor name to see calculations.

If the company EV/EBITDA is lower then the EV/EBITDA of benchmark then company is relatively undervalued.
Otherwise, if the company EV/EBITDA is higher then the EV/EBITDA of benchmark then company is relatively overvalued.


Enterprise Value to EBITDA Ratio, Historical

HCA Healthcare Inc., historical EV/EBITDA calculation, comparison to benchmarks

Microsoft Excel
Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2017
Selected Financial Data (US$ in millions)
Enterprise value (EV)1 109,659 91,822 85,468 82,972 69,421
Earnings before interest, tax, depreciation and amortization (EBITDA)2 14,252 9,735 9,664 9,368 8,202
Valuation Ratio
EV/EBITDA3 7.69 9.43 8.84 8.86 8.46
Benchmarks
EV/EBITDA, Competitors4
Abbott Laboratories 17.42 25.99 21.70
Cigna Group 9.06 6.31 8.42
CVS Health Corp. 10.41 8.56 9.43
Elevance Health Inc. 10.05 7.57 9.05
Humana Inc. 11.22 6.91 9.30
Intuitive Surgical Inc. 44.54 59.12 37.53
Medtronic PLC 24.41 17.92 16.01
UnitedHealth Group Inc. 17.39 13.39 13.82
EV/EBITDA, Sector
Health Care Equipment & Services 15.20 12.74 12.95
EV/EBITDA, Industry
Health Care 13.31 16.61 14.16

Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31).

1 See details »

2 See details »

3 2021 Calculation
EV/EBITDA = EV ÷ EBITDA
= 109,659 ÷ 14,252 = 7.69

4 Click competitor name to see calculations.

Valuation ratio Description The company
EV/EBITDA Enterprise value to earnings before interest, tax, depreciation and amortization is a valuation indicator for the overall company rather than common stock. HCA Healthcare Inc. EV/EBITDA ratio increased from 2019 to 2020 but then decreased significantly from 2020 to 2021.